We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.1B
AUM Growth
Cap. Flow
+$31.1B
Cap. Flow %
99.86%
Top 10 Hldgs %
15.32%
Holding
3,313
New
3,312
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$747M
2
XOM icon
ExxonMobil
XOM
+$735M
3
MSFT icon
Microsoft
MSFT
+$507M
4
CVX icon
Chevron
CVX
+$429M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$427M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 15.07%
2 Technology 13.69%
3 Healthcare 12.3%
4 Industrials 10.73%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
2451
Diageo
DEO
$49B
$314K ﹤0.01%
+2,730
New +$330K
PLPC icon
2452
Preformed Line Products
PLPC
$1.74B
$314K ﹤0.01%
+4,737
New +$344K
TWIN icon
2453
Twin Disc
TWIN
$329M
$314K ﹤0.01%
+13,248
New +$310K
SHOR
2454
DELISTED
ShoreTel, Inc.
SHOR
$314K ﹤0.01%
+78,029
New +$302K
SGYP
2455
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$313K ﹤0.01%
+73,535
New +$369K
CLAR icon
2456
Clarus
CLAR
$123M
$312K ﹤0.01%
+33,310
New +$303K
PEBO icon
2457
Peoples Bancorp
PEBO
$1.5B
$312K ﹤0.01%
+16,299
New +$304K
PLUS icon
2458
ePlus
PLUS
$2.42B
$312K ﹤0.01%
+20,864
New +$258K
CCXI
2459
DELISTED
ChemoCentryx, Inc.
CCXI
$312K ﹤0.01%
+22,058
New +$286K
FBRC
2460
DELISTED
FBR & Co. Common Stock
FBRC
$312K ﹤0.01%
+12,347
New +$271K
VLGEA icon
2461
Village Super Market
VLGEA
$651M
$311K ﹤0.01%
+9,397
New +$328K
USPH icon
2462
US Physical Therapy
USPH
$1.2B
$310K ﹤0.01%
+11,202
New +$296K
BPZ
2463
DELISTED
BPZ RESOURCES INC COM STK
BPZ
$309K ﹤0.01%
+172,579
New +$349K
LVB
2464
DELISTED
STEINWAY MUSICAL INSTRUMENTS
LVB
$309K ﹤0.01%
+10,169
New +$268K
MEG
2465
DELISTED
Media General, Inc
MEG
$308K ﹤0.01%
+27,960
New +$239K
AHRT
2466
AH Realty Trust
AHRT
$529M
$307K ﹤0.01%
+26,080
New +$301K
LUMO
2467
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$307K ﹤0.01%
+1,728
New +$245K
SGNT
2468
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$307K ﹤0.01%
+14,634
New +$262K
CTO
2469
CTO Realty Growth
CTO
$824M
$306K ﹤0.01%
+29,571
New +$304K
NAVB
2470
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$306K ﹤0.01%
+5,735
New +$286K
XNPT
2471
DELISTED
XENOPORT, INC.
XNPT
$306K ﹤0.01%
+61,870
New +$375K
BODY
2472
DELISTED
BODY CENTRAL CORP COM STK
BODY
$306K ﹤0.01%
+22,943
New +$254K
OSUR icon
2473
OraSure Technologies
OSUR
$279M
$305K ﹤0.01%
+78,521
New +$350K
PFC
2474
DELISTED
Premier Financial Corp. Common Stock
PFC
$305K ﹤0.01%
+27,048
New +$307K
HFWA icon
2475
Heritage Financial
HFWA
$1.22B
$304K ﹤0.01%
+20,727
New +$290K

Similar funds

RhumbLine Advisers's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for RhumbLine Advisers, which disclosed 3,313 positions worth $31.1B. Its ten largest holdings account for 15% of the portfolio.

Its largest position is Apple: 48,576,080 shares worth $687M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2013 buy was Apple: 48,576,080 shares worth $687M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $31.1B portfolio in Q2 2013.
  • RhumbLine Advisers disclosed 3,313 positions in Q2 2013, its first 13F filing on record.

Based on RhumbLine Advisers's 13F filing for Q2 2013, filed 7 Aug 2013.